A COST COMPARISON OF TREATMENT WITH ABIRATERONE ACETATE PLUS PREDNISONE IN THE PRE-CHEMOTHERAPY SETTING FOLLOWED BY ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING VERSUS THE OPPOSITE TREATMENT SEQUENCE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS WITH NON-VISCERAL METASTASES IN COLOMBIA

Gamboa O.; Bonilla C.; Varela R.

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >A COST COMPARISON OF TREATMENT WITH ABIRATERONE ACETATE PLUS PREDNISONE IN THE PRE-CHEMOTHERAPY SETTING FOLLOWED BY ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING VERSUS THE OPPOSITE TREATMENT SEQUENCE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS WITH NON-VISCERAL METASTASES IN COLOMBIA

【24h】

A COST COMPARISON OF TREATMENT WITH ABIRATERONE ACETATE PLUS PREDNISONE IN THE PRE-CHEMOTHERAPY SETTING FOLLOWED BY ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING VERSUS THE OPPOSITE TREATMENT SEQUENCE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS WITH NON-VISCERAL METASTASES IN COLOMBIA

机译：在化疗预疗法中，在化疗预疗法中的丙酸盐加上泼尼松治疗的成本比较，然后在化疗后的依齐甲酰胺与哥伦比亚非内脏转移患者的转移阉割前列腺癌患者相反的治疗序列

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2017年第5期|共1页
作者
Gamboa O.; Bonilla C.; Varela R.;
展开▼
作者单位

IECAS Bogota Colombia;

Inst Nacl Cancerol Bogota Colombia;

Inst Nacl Cancerol Bogota Colombia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. A COST COMPARISON OF TREATMENT WITH ABIRATERONE ACETATE PLUS PREDNISONE IN THE PRE-CHEMOTHERAPY SETTING FOLLOWED BY ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING VERSUS THE OPPOSITE TREATMENT SEQUENCE IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER PATIENTS WITH NON-VISCERAL METASTASES IN COLOMBIA [J] . Gamboa O., Bonilla C., Varela R. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：在化疗预疗法中，在化疗预疗法中的丙酸盐加上泼尼松治疗的成本比较，然后在化疗后的依齐甲酰胺与哥伦比亚非内脏转移患者的转移阉割前列腺癌患者相反的治疗序列
2. NUMBER NEEDED TO TREAT AND ASSOCIATED INCREMENTAL COSTS OF TREATMENT WITH ENZALUTAMIDE VERSUS ABIRATERONE ACETATE PLUS PREDNISONE IN CHEMOTHERAPY-NAIVE PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN SPAIN AND THE UNITED KINGDOM [J] . Duran A., Watt M., Flanders S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：治疗和相关的烯醇胺治疗的醋酸盐和血液治疗中的化疗 - 幼稚患者的抗泼尼松治疗的数量，在西班牙和英国的转移阉割前列腺癌中
3. Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis [J] . J. Cassinello, T. Dominguez-Lubillo, M. Gomez-Barrera, Cancer Treatment Reviews . 2021,第1期

机译：抗阉割转移前列腺癌患者AbiraTerone醋酸盐加上泼尼松和烯醇酰胺的最佳处理测序：系统评价与荟萃分析
4. Treatment Duration Healthcare Resource Utilization and Costs Among Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide or Abiraterone Acetate: A Retrospective Claims Analysis [O] . Neil M. Schultz, Scott C. Flanders, Samuel Wilson, -1

机译：恩扎鲁胺或醋酸阿比特龙治疗的初治转移性去势抵抗性前列腺癌患者的治疗持续时间医疗资源利用和费用：回顾性索赔分析
5. PCN93 A Cost Comparison of Treatment with Abiraterone Acetate Plus Prednisone in the Pre Chemotherapy Setting Followed By Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration Resistant Prostate Cancer Patients With non-Visceral Metastases [O] . Dearden L, Girod I, Majer I, 2015

机译：PCN93在化疗前环境中使用醋酸阿比特龙+泼尼松治疗，化疗后环境中使用恩扎鲁胺治疗与转移性去势抵抗性前列腺癌非内脏转移患者相反治疗顺序的成本比较

著录项

相似文献

相关主题

期刊订阅